<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03208569</url>
  </required_header>
  <id_info>
    <org_study_id>Studie ACB</org_study_id>
    <nct_id>NCT03208569</nct_id>
  </id_info>
  <brief_title>Anticholinergic Burden - Treatment Optimization</brief_title>
  <official_title>Treatment Optimization Regarding Anticholinergic Medications Potential Impact on Cognitive Test Performance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Region Skane</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Angelholm Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Region Skane</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is increasing evidence that medications with anticholinergic effects may adversely
      affect cognitive function. Older adults are particularly sensitive to anticholinergic effects
      because of changes in pharmacokinetics and pharmacodynamics. The cumulative effect of taking
      one or more medicines with anticholinergic properties is referred to as anticholinergic
      burden. To estimate the anticholinergic burden, Boustani et al. published the Anticholinergic
      Cognitive Burden scale (2008). The objective of this study is to measure the association
      between the use of medications with anticholinergic properties (identified by the ACB scale)
      and cognitive performance. Anticholinergic use and cognitive performance will be measured at
      baseline and 6-months follow-up.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2017</start_date>
  <completion_date type="Anticipated">September 2021</completion_date>
  <primary_completion_date type="Anticipated">September 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cognitive function</measure>
    <time_frame>6 months</time_frame>
    <description>Cognitive function, measured by the Mini-Mental State Examination (MMSE)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anticholinergic burden</measure>
    <time_frame>6 months</time_frame>
    <description>Anticholinergic burden, determined according to the Anticholinergic Burden scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive function</measure>
    <time_frame>6 months</time_frame>
    <description>Cognitive function, measured by Montreal Cognitive Assessment (MOCA)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive function</measure>
    <time_frame>6 months</time_frame>
    <description>Cognitive function, measured by the Trail Making Test A &amp; B (TMT)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive function</measure>
    <time_frame>6 months</time_frame>
    <description>Cognitive function, measured by The Alzheimer´s Disease Assessment Scale - Cognitive subscale (ADAS-Cog)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive function</measure>
    <time_frame>6 months</time_frame>
    <description>Cognitive function, measured by the Symbol Digit Modalities Test (SDMT)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cognitive function</measure>
    <time_frame>6 months</time_frame>
    <description>Cognitive function, measured by A Quick Test of cognitive speed (AQT)</description>
  </secondary_outcome>
  <enrollment type="Anticipated">700</enrollment>
  <condition>Anticholinergics</condition>
  <condition>Cognitive Function</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The study population includes individuals aged ≥ 50 at the Memory Clinic, Hospital of
        Ängelholm
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  50 years and older
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Per Johansson, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Region Skåne</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Per Johansson, MD, PhD</last_name>
    <phone>+46(0)709-105103</phone>
    <email>per.m.johansson@skane.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tanja Lehtinen, MScPharm</last_name>
    <phone>+46(0)431-81597</phone>
    <email>tanja.lehtinen@skane.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Specialistminnesmottagningen</name>
      <address>
        <city>Ängelholm</city>
        <zip>26281</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Per Johansson, MD,PhD</last_name>
      <phone>+46 431-815 74</phone>
      <email>per.m.johansson@skane.se</email>
    </contact>
    <contact_backup>
      <last_name>Tanja Lehtinen, MScPharm</last_name>
      <phone>+46 431-815 97</phone>
    </contact_backup>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 27, 2017</study_first_submitted>
  <study_first_submitted_qc>July 3, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 5, 2017</study_first_posted>
  <last_update_submitted>March 1, 2018</last_update_submitted>
  <last_update_submitted_qc>March 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>anticholinergic</keyword>
  <keyword>alzheimer</keyword>
  <keyword>cognition</keyword>
  <keyword>MMSE</keyword>
  <keyword>anticholinergic cognitive burden scale</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholinergic Antagonists</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

